United States Multi-Omics Market Outlook 2025: Forecast to GCC, Key Developments, Growth Drivers, Key Players & Investment Opportunities

Multi omics Market reached US$ 3.25 Billion in 2024 and is expected to reach US$ 33.25 Billion by 2033, growing at a CAGR of 26.1% during the forecast period 2025-2033

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/multiomics-market?kb

United States - Recent Industry Developments

✅ Nov 2025: Thermo Fisher Scientific launched an AI-powered multi-omics platform integrating genomics, proteomics, and metabolomics for precision medicine.

✅ Oct 2025: Illumina expanded multi-omics sequencing partnerships with top U.S. cancer research institutions to accelerate biomarker discovery.

✅ Sep 2025: NIH increased funding for multi-omics clinical programs focused on rare disease diagnostics and preventative therapeutics.

Japan - Recent Industry Developments

✅ Nov 2025: RIKEN introduced a high-resolution multi-omics analysis workflow to support early detection of neurodegenerative diseases.

✅ Oct 2025: Fujifilm and Takeda launched multi-omics-driven drug discovery projects using advanced proteomics and lipidomics datasets.

✅ Sep 2025: Japanese multi-omics data cloud services expanded to support hospital-level implementation of personalized treatment models.

GCC - Recent Industry Developments

✅ Nov 2025: King Faisal Specialist Hospital (Saudi Arabia) deployed its first multi-omics precision oncology program for real-time clinical decision support.

✅ Oct 2025: UAE launched a national multi-omics infrastructure initiative to integrate population genomics, proteomics, and metabolomics research.

✅ Sep 2025: Qatar Foundation funded large-scale chronic disease studies using multi-omics datasets to enhance predictive public health models.

Major Growing Players:

BD (Becton, Dickinson, and Company), Thermo Fisher Scientific Inc., Illumina, Inc., Danaher Corporation, Bruker Corporation, QIAGEN N.V, Agilent Technologies, Inc., Genedata, Shimadzu Corporation, and Element Biosciences

Key Developments:

In May 2024, QIAGEN introduced the QIAseq Multimodal DNA/RNA Library Kit, designed to prepare both DNA and RNA libraries for next-generation sequencing from a single sample. It supports whole genome and whole transcriptome sequencing and enables downstream hybrid-capture-based target enrichment.

In June 2023, Singleton unveiled two new single-cell multi-omics solutions - NEO and Python Junior. These compact systems are engineered to fit any laboratory setup while ensuring high accuracy and reproducibility. The NEO library processing platform and the Python Junior tissue dissociation instrument are intended to make single-cell sequencing more accessible for researchers and clinicians across all lab environments.

Forecast Projection:

The Global Multi Omics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Global Multi Omics Market report is built on solid intelligence - powered by both primary and secondary research. Our analysts have deep-dived into every factor that can influence your business roadmap, including government regulations, competitive landscape, tech innovations, historical market behavior, upcoming breakthroughs, adjacent industry trends, market volatility, growth prospects, and potential risks.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=multiomics-market?kb

Key Segments:

By Product & Service: Instruments, Consumables & Reagents, Services

By Technology: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

By Application: Drug Discovery & Development, Precision Medicine, Clinical Diagnostics, Biotechnology & Industrial Applications

By End-User: Pharmaceutical & Biotechnology Companies, Research Institutes & Academic Centers, Hospitals & Clinics, CROs & CDMOs

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: sets the stage by defining the full scope of the report and delivering an executive summary of key market segments across regions, product types, and applications. It provides a comprehensive snapshot of current market sizes and reveals future growth potential, offering a clear vision of how the market will evolve in the short, mid, and long term.

Chapter 2: uncovers critical insights and highlights the most impactful emerging trends shaping the Multi Omics market's future - essential knowledge for investors and strategists looking to stay ahead.

Chapter 3: dives deep into the competitive landscape, delivering an in-depth analysis of Multi Omics manufacturers. It covers market share dynamics, strategic developments, and the latest mergers and acquisitions that are redefining the industry.

Chapter 4: profiles the market's leading players, offering detailed views of their revenue streams, profit margins, product portfolios, and recent innovations - arming you with the intel to benchmark and strategize effectively.

Chapters 5 & 6: break down revenue performance by region and country, providing a quantitative analysis that spotlights growth hotspots, development prospects, and the unique opportunities each market offers across the globe.

Chapter 7: explores market segmentation by type, revealing the size and untapped potential of each segment - guiding you toward lucrative "blue ocean" opportunities that competitors may have overlooked.

Chapter 8: analyzes the market by application, evaluating downstream sectors with the highest growth potential and identifying promising areas for expansion and investment.

Chapter 9: maps the entire industry supply chain, tracing upstream suppliers to downstream distributors, giving you full visibility into critical business linkages and value drivers.

Chapter 10: wraps up with a powerful summary of the report's key findings and strategic takeaways, delivering the must-know insights every industry stakeholder needs to make confident, forward-looking decisions.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/multiomics-market?kb

FAQ's

Q1: How fast Multi Omics Market Growing?

A: The Multi Omics Market was valued at US$ 3.25 Billion in 2024 and is on track for explosive expansion, projected to hit US$ 33.25 Billion by 2033

Q2: How fast is the Multi Omics Market growing?

A: The Market is set to surge with an impressive CAGR of 26.1% between 2025 and 2032

Have Detailed Enquiry of This Report @ https://www.datamintelligence.com/enquiry/multiomics-market?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.